Mara L. Becker

4.4k total citations
76 papers, 1.3k citations indexed

About

Mara L. Becker is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Speech and Hearing. According to data from OpenAlex, Mara L. Becker has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 31 papers in Public Health, Environmental and Occupational Health and 16 papers in Speech and Hearing. Recurrent topics in Mara L. Becker's work include Autoimmune and Inflammatory Disorders Research (42 papers), Acute Lymphoblastic Leukemia research (21 papers) and Adolescent and Pediatric Healthcare (16 papers). Mara L. Becker is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (42 papers), Acute Lymphoblastic Leukemia research (21 papers) and Adolescent and Pediatric Healthcare (16 papers). Mara L. Becker collaborates with scholars based in United States, Canada and Spain. Mara L. Becker's co-authors include J. Steven Leeder, Leon van Haandel, Carlos D. Rosé, Ryan S. Funk, Elizabeth A. Kessler, John F. Stobaugh, Roger Gaedigk, Mark F. Hoeltzel, Ashley Sherman and Andrew Lasky and has published in prestigious journals such as Gastroenterology, PEDIATRICS and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mara L. Becker

73 papers receiving 1.3k citations

Peers

Mara L. Becker
Danny M. Cohn Netherlands
R.L. Pisoni United States
Claudia Marx Germany
Catherine A. Williams United States
Suzanne M. Norby United States
H A Capell United Kingdom
Robert W. Sponzo United States
Mara L. Becker
Citations per year, relative to Mara L. Becker Mara L. Becker (= 1×) peers Motoshi Hattori

Countries citing papers authored by Mara L. Becker

Since Specialization
Citations

This map shows the geographic impact of Mara L. Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara L. Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara L. Becker more than expected).

Fields of papers citing papers by Mara L. Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara L. Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara L. Becker. The network helps show where Mara L. Becker may publish in the future.

Co-authorship network of co-authors of Mara L. Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Mara L. Becker. A scholar is included among the top collaborators of Mara L. Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara L. Becker. Mara L. Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortega, Pilar, Mara L. Becker, Teresa M. Chan, & Kimberly D. Manning. (2025). Beyond Traditional: Clearing the Roadblocks to Advancement in Academic Medicine. Perspectives on Medical Education. 14(1). 286–295. 1 indexed citations
3.
Shakhnovich, Valentina, Marc Sudman, Daniel J. Lovell, et al.. (2024). Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis. Metabolites. 14(9). 499–499. 1 indexed citations
4.
Baumer, Nicole, Mara L. Becker, George T. Capone, et al.. (2022). Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group. Journal of Neurodevelopmental Disorders. 14(1). 22–22. 25 indexed citations
5.
Funk, Ryan S., et al.. (2021). Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease. Pharmaceuticals. 14(5). 463–463. 6 indexed citations
6.
Becker, Mara L., et al.. (2021). Distinguishing Blau Syndrome from Systemic Sarcoidosis. Current Allergy and Asthma Reports. 21(2). 10–10. 26 indexed citations
7.
Pasnoor, Mamatha, Andrew Heim, Laura Herbelin, et al.. (2020). Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial. Kansas Journal of Medicine. 13(Suppl 2). 10–13. 3 indexed citations
8.
Li, Suzanne C., Kathryn S. Torok, C. Egla Rabinovich, et al.. (2019). Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma. The Journal of Rheumatology. 47(8). 1242–1252. 20 indexed citations
9.
Singh, Rakesh K., Leon van Haandel, Daniel P. Heruth, et al.. (2018). Nicotinamide Phosphoribosyltransferase Deficiency Potentiates the Antiproliferative Activity of Methotrexate through Enhanced Depletion of Intracellular ATP. Journal of Pharmacology and Experimental Therapeutics. 365(1). 96–106. 6 indexed citations
10.
Kessler, Elizabeth A., Ashley Sherman, & Mara L. Becker. (2016). Decreasing patient cost and travel time through pediatric rheumatology telemedicine visits. Pediatric Rheumatology. 14(1). 54–54. 62 indexed citations
11.
Becker, Mara L.. (2015). Using Methotrexate Metabolites to Make Clinical Decisions in JIA. 1(4). 381–395. 3 indexed citations
12.
Hashkes, Philip J., Mara L. Becker, David A. Cabral, et al.. (2013). Methotrexate: New Uses for an Old Drug. The Journal of Pediatrics. 164(2). 231–236. 53 indexed citations
13.
Dai, Hongying, et al.. (2012). Global tests of P-values for multifactor dimensionality reduction models in selection of optimal number of target genes. BioData Mining. 5(1). 3–3. 7 indexed citations
14.
Becker, Mara L., Leon van Haandel, Roger Gaedigk, et al.. (2012). Red blood cell folate concentrations and polyglutamate distribution in juvenile arthritis. Pharmacogenetics and Genomics. 22(4). 236–246. 21 indexed citations
15.
Becker, Mara L.. (2012). Optimization of Pediatric Rheumatology Therapeutics. Clinical Pharmacology & Therapeutics. 91(4). 597–606. 13 indexed citations
16.
Becker, Mara L., Roger Gaedigk, Leon van Haandel, et al.. (2010). The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response. Arthritis & Rheumatism. 63(1). 276–285. 60 indexed citations
19.
Haandel, Leon van, Mara L. Becker, J. Steven Leeder, Todd D. Williams, & John F. Stobaugh. (2009). A novel high‐performance liquid chromatography/mass spectrometry method for improved selective and sensitive measurement of methotrexate polyglutamation status in human red blood cells. Rapid Communications in Mass Spectrometry. 23(23). 3693–3702. 35 indexed citations
20.
Becker, Mara L. & Carlos D. Rosé. (2005). Blau syndrome and related genetic disorders causing childhood arthritis. Current Rheumatology Reports. 7(6). 427–433. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026